Latest Share Chat

Genedrive Share News (GDR)

Genedrive Information

Buy GDR Shares
Add GDR to Watchlist
Add GDR to Alert

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 4.625

Bid: 4.50

Ask: 4.75

Change: 0.225 (5.11%)

Spread: 0.25 (5.556%)

Open: 4.625

High: 4.625

Low: 4.625

Prev. Close: 4.40

Last checked at -

IN BRIEF: Genedrive wins distribution agreements for Covid-19 test

Wed, 23rd Feb 2022 14:22

Genedrive PLC - Manchester-based molecular diagnostics company - Enters into distribution agreements covering Spain, Portugal, Oman and the United Arab Emirates for its Covid-19 test kit. The company says these initial distributor arrangements are designed to access and assess the longer-term market potential in each country. Genedrive says end-user product evaluation in the UK is currently ongoing and Covid-19 test device approval is pending.

Current stock price: 17.79 pence, up 23% on Wednesday

12-month change: down 84%

By Heather Rydings; heatherrydings@alliancenews.com

More News

25 Jun 2021 14:39

IN BRIEF: Genedrive receives Indian import license for Covid test kit

30 Apr 2021 13:16

Genedrive Covid-19 test formally approved in India

(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that the 'Genedrive 96' SARS-CoV-2 kit had been formally approved by the Indian Council of Medical Research (ICMR).

30 Apr 2021 10:51

Genedrive shares surge after Covid test approved by Indian regulator

30 Apr 2021 10:40

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

23 Apr 2021 10:02

Genedrive says study shows kit is effective at diagnosing Hepatitis C

19 Apr 2021 14:10

UPDATE: Yourgene wins further national framework contract award

19 Apr 2021 12:46

IN BRIEF: Genedrive included in Public Health England framework

19 Apr 2021 12:07

Genedrive appointed to PHE microbiology supply framework

(Sharecast News) - Molecular diagnostics company Genedrive has been successful with its tender to Public Health England (PHE) under Lot 1 of the National Microbiology Framework for diagnostic goods and services, it announced on Monday.

19 Apr 2021 11:44